# OnCo record hopec-pharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/hopec-pharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "hopec-pharma" ;
  schema:name "Hopec Pharma"@en ;
  schema:alternateName "HOPEC Pharma"@en, "Hopec-Pharma"@en ;
  schema:description "Hopec Pharma is an Israeli company developing an immune treatment for early bladder cancer made from an inactivated, genetically modified E. coli bacterium. It is in a first trial in people whose cancer came back after BCG or chemotherapy in the bladder."@en ;
  schema:url <https://onco.cc/companies/hopec-pharma/>, <https://www.hopec-pharma.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.hopec-pharma.com/>, <https://www.hopec-pharma.com/about>, <https://clinicaltrials.gov/study/NCT07881666> ;
  schema:addressCountry "IL" ;
  onco:cancers <https://onco.cc/cancers/non-muscle-invasive-bladder-cancer/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/bcg-and-intravesical-therapy/> .